CD63 and colonic neoplasm: For sEVs recovery experiments, we used the human colon cancer cell line, HT29-CD63-Nluc, which ectopically expresses Nanoluc, a highly sensitive luciferase fused with CD63, as an sEV marker (Hikita et al., 2018).